Day: August 30, 2022

Permex Petroleum Reports Successful Recompletion of wells on its New Mexico and Texas Properties

Written by Customer Service on August 30, 2022. Posted in Public Companies.

Company Successfully Recompletes Five Oil & Gas wells VANCOUVER, British Columbia, Aug. 30, 2022 (GLOBE NEWSWIRE) — Permex Petroleum Corporation (CSE: OIL) (OTCQB: OILCF) (FSE: 75P) (“Permex” or the “Company“), a junior oil and gas company, is pleased to announce results obtained from five recently recompleted oil and gas wells located in Eddy County, New Mexico and Martin County, Texas. In August, Permex continued its re-entry and stimulation program on its Henshaw Premier Unit and Oxy Yates properties situated in Eddy County New Mexico. The re-entry and stimulations involved targeting the Grayburg formation in the Henshaw well numbers 107, 2L, 3B, while targeting the Yates formation in Oxy yates 14-3 well. The Company also recompleted the Mabee Breedlove Clearfork Unit #12 (“MBCU”) on its Breedlove...

Adagene Reports Financial Results for the Six Months Ended June 30, 2022 and Provides Corporate Updates

Written by Customer Service on August 30, 2022. Posted in Earnings Releases And Operating Results.

– Topline data for anti-CTLA-4 antibody, ADG116, shows compelling clinical safety and complete and partial responses as both a single agent and in combination with anti-PD-1 therapy; results to be presented at SITC 2022 – – Masked, anti-CTLA-4 antibody, ADG126, safely dosed repeatedly up to 20 mg/kg as a single agent with encouraging efficacy signals; results to be presented at ESMO 2022 – – Presentation of combination dosing data with anti-PD-1 therapies in 2022, while dose expansion begins for both ADG116 and ADG126 in targeted tumors – – Submitted regulatory filing for clinical trial of masked, IgG1-based anti-CD137 candidate, ADG206, with greater preclinical potency than the analog of a benchmark antibody, urelumab, that demonstrated monotherapy efficacy in clinic; patient dosing planned in early 2023 – – Cash balance of US$168 million...

Red White & Bloom Reports Financial Results for Second Quarter 2022 and Six Months Ended June 30th 2022

Written by Customer Service on August 30, 2022. Posted in Earnings Releases And Operating Results.

Q2 2022 revenue increased 225% to CDN $27.4 million, vs CDN $12.2 million in Q2 20211 Revenue for the 6 months ended June 30th 2022 increased 235% to CDN $55.4 million from CDN $23.6 million with Gross Margin excluding biological assets of $16.1 million1 Executed agreements for much anticipated PV licensed product for distribution in two high potential states Paid down CDN $51.7m of debt and eliminated CDN $6.2m of annual interest expenseTORONTO, Aug. 30, 2022 (GLOBE NEWSWIRE) — Red White & Bloom Brands Inc. (CSE: RWB and OTC: RWBYF) (“RWB” or the “Company”) is pleased to report it has filed its 2022 second quarter financial statements and related Management’s Discussion and Analysis and is providing certain Q2, 2022 financial results and select subsequent events: Management Commentary: Brad Rogers, CEO and Chairman...

First Commonwealth Financial Corporation Extends its Pennsylvania Presence with Acquisition of Centric Financial Corporation

Written by Customer Service on August 30, 2022. Posted in Mergers And Acquisitions.

INDIANA, Pa. and HARRISBURG, Pa., Aug. 30, 2022 (GLOBE NEWSWIRE) — First Commonwealth Financial Corporation (“First Commonwealth”) (NYSE: FCF) and Centric Financial Corporation (“Centric”) (OTCPink: CFCX) today jointly announced the signing of a definitive Agreement and Plan of Merger providing for the merger of Centric with and into First Commonwealth in an all-stock transaction valued at approximately $16.20 per share, or approximately $144 million in the aggregate, based upon the preceding 10-day volume weighted average closing stock price of First Commonwealth as of Monday, August 29, 2022. Following the merger of the parent holding companies, Centric’s subsidiary, Centric Bank, will merge with and into First Commonwealth’s subsidiary, First Commonwealth Bank. The business combination will produce a combined company with approximately...

Balchem Corporation acquires Bergstrom Nutrition

Written by Customer Service on August 30, 2022. Posted in Mergers And Acquisitions.

NEW HAMPTON, N.Y., Aug. 30, 2022 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ:BCPC), a global specialty ingredients company focused on Nutrition and Health, today announced the acquisition of Cardinal Associates Inc., operating as “Bergstrom Nutrition,” a leading science-based manufacturer of methylsulfonylmethane (MSM), based in Vancouver, Washington. MSM is a widely used nutritional ingredient with strong scientific evidence supporting its benefits for joint health, sports nutrition, skin and beauty, healthy aging, and pet health. Bergstrom Nutrition’s MSM brand “OptiMSM®” delivers the highest quality and purity MSM on the market and is the only brand of MSM with a U.S. GRAS “generally regarded as safe” designation. Ted Harris, Chairman, CEO and President of Balchem, said, “We are excited to welcome Bergstrom Nutrition to Balchem....

HP Inc. Reports Fiscal 2022 Third Quarter Results

Written by Customer Service on August 30, 2022. Posted in Earnings Releases And Operating Results.

PALO ALTO, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) — HP (NYSE: HPQ)Third quarter GAAP diluted net earnings per share (“EPS”) of $1.08, above the previously provided outlook of $0.91 to $0.96 per share Third quarter non-GAAP diluted net EPS of $1.04, within the previously provided outlook of $1.03 to $1.08 per share Third quarter net revenue of $14.7 billion, down 4.1% from the prior-year period Third quarter net cash provided by operating activities of $0.4 billion, free cash flow of $0.3 billion Third quarter returned $1.3 billion to shareholders in the form of share repurchases and dividendsHP Inc.’s fiscal 2022 third quarter financial performance Q3 FY22 Q3 FY21 Y/Y GAAP net revenue ($B) $ 14.7 $ 15.3 (4.1)% GAAP operating margin 8.7% 9.0% (0.3) pts GAAP net earnings...

A-Mark Precious Metals Announces Fiscal Fourth Quarter and Full Year 2022 Results

Written by Customer Service on August 30, 2022. Posted in Earnings Releases And Operating Results.

FY 2022 Non-GAAP Adjusted Net Income of $195.0 million – up from $179.9 million in FY 2021 270% YoY Increase in Direct-to-Consumer Active Customers Company Declares Non-recurring Special Dividend of $1.00 and Announces Regular Quarterly Cash Dividend Policy of $0.20 per share ($0.80 per share on an annual basis) Over $8.1 Billion of Revenues for Full Year 2022 EL SEGUNDO, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) — A-Mark Precious Metals, Inc. (NASDAQ: AMRK), a leading fully integrated precious metals platform, reported results today for the fiscal fourth quarter and full year ended June 30, 2022. Fiscal Fourth Quarter 2022 Operational HighlightsGold ounces sold in the three months ended June 30, 2022 decreased 17% to 641,000 ounces from 772,000 ounces for the three months ended June 30, 2021, and decreased 12% from 727,000...

Ambarella, Inc. Announces Second Quarter Fiscal Year 2023 Financial Results

Written by Customer Service on August 30, 2022. Posted in Earnings Releases And Operating Results.

SANTA CLARA, Calif, Aug. 30, 2022 (GLOBE NEWSWIRE) — Ambarella, Inc. (NASDAQ: AMBA), an edge AI vision silicon company, today announced financial results for its second quarter of fiscal year 2023 ended July 31, 2022.Revenue for the second quarter of fiscal 2023 was $80.9 million, up 2% from $79.3 million in the same period in fiscal 2022. For the six months ended July 31, 2022, revenue was $171.2 million, up 15% from $149.5 million for the six months ended July 31, 2021. Gross margin under U.S. generally accepted accounting principles (GAAP) for the second quarter of fiscal 2023 was 63.1%, compared with 62.3% for the same period in fiscal 2022. For the six months ended July 31, 2022, GAAP gross margin was 62.9%, compared with 62.3% for the six months ended July 31, 2021. GAAP net loss for the second quarter of fiscal 2023 was...

Athene Holding Ltd. Declares Third Quarter 2022 Preferred Stock Dividends

Written by Customer Service on August 30, 2022. Posted in Dividend Reports And Estimates.

HAMILTON, Bermuda, Aug. 30, 2022 (GLOBE NEWSWIRE) — Athene Holding Ltd. (“Athene”) announced that it has declared the following preferred stock dividends on its non-cumulative preference shares (represented by depositary shares, each representing a 1/1,000th interest in a preference share), payable on September 30, 2022 to holders of record as of September 15, 2022.Quarterly dividend of $396.875 per share on the company’s 6.35% Fixed-to-Floating Rate Perpetual Non-Cumulative Preference Shares, Series A (the “Series A Preference Shares”); holders of depositary shares will receive $0.396875 per depositary share. Quarterly dividend of $351.5625 per share on the company’s 5.625% Fixed Rate Perpetual Non-Cumulative Preference Shares, Series B (the “Series B Preference Shares”); holders of depositary shares will receive $0.3515625...

Oncocyte Announces Five-Year VA Contract for DetermaRx

Written by Customer Service on August 30, 2022. Posted in Public Companies.

IRVINE, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) — Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company with the mission to improve patient outcomes by providing personalized insights that inform critical decisions throughout the patient care journey, today announced that the US Department of Veterans Affairs (“VA”), the largest integrated health care system in the United States, has awarded a Federal Supply Schedule Contract for the Company’s DetermaRx™ test. The VA provides care at 1,293 health care facilities, including 171 VA Medical Centers and 1,112 outpatient sites of care of varying complexity to over 9 million veterans enrolled in the VA health care program. The contract is for a period of five years. “We are excited by the VA’s recognition of the value of DetermaRx,” said Ron Andrews, Chief Executive Officer...

Day: August 30, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice